ArticleDiabetology & metabolic syndrome2026

Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial.

Awadhesh Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.